Discover
RGC
Regencell Bioscience Holdings Limited
8.03
2 x 6.12
2 x 10.07
bid
ask
+
1.94
31.86%
2 @ 07:12 AM
8.04 +0.01 (0.12%)
| Ytd | -61.76% | |
| 1y | -22.49% |
6.00
day range
8.78
5.80
52 week range
69.00
| Open | 6.02 | Prev Close | 6.09 | Low | 6.00 | High | 8.78 | Mkt Cap | 3.97B |
| Vol | 2.54M | Avg Vol | 189.97K | EPS | -0.01 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.64 | Short Ratio | 7.79 | Inst. Own | 0.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 06-15 | 50-d Avg | 22.17 | 200-d Avg | 22.23 | 1yr Est | 0.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2018-03-01 | 2017-12 | 0.34 | N/A | N/A | N/A |
| 2017-10-24 | 2017-09 | 0.04 | N/A | N/A | N/A |
| 2017-07-26 | 2017-06 | 0.18 | N/A | N/A | N/A |
| 2017-04-26 | 2017-03 | 0.36 | N/A | N/A | N/A |
| 2017-02-09 | 2016-12 | 0.26 | N/A | N/A | N/A |
| 2016-10-27 | 2016-09 | 0.26 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | Geode Capital Management, LLC | 415.57K | 3.34M | 0.08% |
| 2026-03-30 | GSA Capital Partners LLP | 31.57K | 253.50K | 0.01% |
| 2026-03-30 | Marex Group Plc | 31.60K | 253.75K | 0.01% |
| 2026-03-30 | Vident Advisory, LLC | 29.59K | 237.59K | 0.01% |
| 2026-03-30 | Squarepoint Ops LLC | 26.61K | 213.70K | 0.01% |
| 2026-03-30 | UBS Group AG | 23.89K | 191.80K | 0.00% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-04-29 | Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 300.32K | 2.41M | 0.06% |
| 2026-05-30 | Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 120.88K | 970.66K | 0.02% |
| 2026-05-30 | BNY Mellon ETF Trust-BNY Mellon International Equity ETF | 2.56K | 20.58K | 0.00% |
| 2026-05-30 | SPDR INDEX SHARES FUNDS-State Street SPDR S&P China ETF | 3.90K | 31.28K | 0.00% |
| 2026-05-30 | Goldman Sachs ETF TRT-Goldman Sachs MarketBeta Intl Eqy. ETF | 1.40K | 11.24K | 0.00% |
| 2026-05-30 | Goldman Sachs ETF TRT II-Goldman Sachs MarketBeta Total Intl Eqy. ETF | 1.12K | 9.00K | 0.00% |
Dividend
| Dividend | Date |
|---|---|
| 8.36 | 2018-02-15 |
| 8.36 | 2017-12-01 |
| 8.36 | 2017-08-31 |
| 8.36 | 2017-06-01 |
| 8.36 | 2017-03-01 |
| 8.36 | 2016-12-01 |
Split
| Split | Date |
|---|---|
| 38 : 1 | 2025-06-16 |